Cedars-Sinai Marina del Rey Hospital Now Offers ORBERA™ Intragastric Balloon

Marina del Rey, CA – August 9, 2016: Cedars-Sinai Marina del Rey Hospital is excited to share that the U.S. Food and Drug Administration has approved ORBERA™ to assist adult patients suffering from obesity – with a body mass index (BMI) of 30 to 40 – in losing and maintaining weight.

ORBERA™ is a safe and effective weight loss solution with 20 years of global experience and real world results. More than 220,000 ORBERA™ balloons distributed worldwide in over 80 countries. The Marina Weight Loss Center is thrilled to offer this new tool in helping people achieve their weight loss goals.

“ORBERA is a wonderful option for someone who wants to lose weight quickly, yet safely, without surgery,” says Dr. Jeremy Korman, MD, FACS, Marina Weight Loss Center. “We believe the ORBERA Managed Weight Loss System will play a key role in the prevention of obesity in many cases and we are thrilled to be one of the first healthcare facilities to offer it in our community.”

The ORBERA™ balloon is part of the ORBERA Managed Weight Loss System, a comprehensive, non-surgical two-part program that includes a balloon filling space in a patient’s stomach to reinforce proper portion control. Data on ORBERA™ collected in the U.S. clinical trial has shown that the average person lost 3.1 times the weight as compared with diet and exercise alone within six months.

The Marina Weight Loss Center recognizes that obesity is a chronic disease and is pleased to be able to offer new, minimally invasive solutions, like ORBERA™, to help transform the lives of patients before their disease progresses and requires more invasive treatment.

For additional information regarding ORBERA™, please visit orbera.com and orbera.com/dfu. For more information on ORBERA™ at Cedars-Sinai Marina del Rey Hospital and to schedule a free consultation, please call 310-577-5540 or click here.

Media Contacts:

Bridgette Agee
Marina Weight Loss Center

Angela Moore
Starfish Public Relations